{"id":932,"date":"2024-11-14T11:00:02","date_gmt":"2024-11-14T10:00:02","guid":{"rendered":"https:\/\/www.dgrpharma.com\/?p=932"},"modified":"2025-09-09T21:21:18","modified_gmt":"2025-09-09T19:21:18","slug":"glp","status":"publish","type":"post","link":"https:\/\/www.dgrpharma.com\/cms19\/glp\/","title":{"rendered":"GLP"},"content":{"rendered":"<p><span style=\"color: #000000; font-family: Calibri;\">The DGr Pharma team is pleased to announce having obtained the endorsement of GLP compliance for the conduct of pharmacokinetic and toxicokinetic analyses after successfully passing again the GLP inspection by the Dutch GLP authority (IGJ). Please refer to the <!--more-->published list of \u00a0IGJ inspected test facilities in The Netherlands (<\/span><a href=\"https:\/\/english.igj.nl\/medicines\/documents\/publication\/2017\/03\/08\/glp-domestic-test-facilities\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/english.igj.nl\/medicines\/documents\/publication\/2017\/03\/08\/glp-domestic-test-facilities<\/a><span style=\"color: #000000; font-family: Calibri;\">).<\/span><\/p>\n<p><span style=\"color: #000000; font-family: Calibri;\">For further inquiries, contact our CEO Kees Groen at <\/span><a>Kees.Groen@DGrPharma.com<\/a><\/p>\n<p><a href=\"https:\/\/www.dgrpharma.com\/cms19\/wp-content\/uploads\/2024\/11\/DGr-Pharma-20241031-Endorsement.pdf\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-927 size-medium\" src=\"https:\/\/www.dgrpharma.com\/cms19\/wp-content\/uploads\/2020\/09\/GLP-300x180.jpg\" alt=\"\" width=\"300\" height=\"180\" srcset=\"https:\/\/www.dgrpharma.com\/cms19\/wp-content\/uploads\/2020\/09\/GLP-300x180.jpg 300w, https:\/\/www.dgrpharma.com\/cms19\/wp-content\/uploads\/2020\/09\/GLP.jpg 443w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The DGr Pharma team is pleased to announce having obtained the endorsement of GLP compliance for the conduct of pharmacokinetic and toxicokinetic analyses after successfully passing again the GLP inspection by the Dutch GLP authority (IGJ). Please refer to the<\/p>\n","protected":false},"author":3,"featured_media":1224,"comment_status":"closed","ping_status":"closed","sticky":true,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-932","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/www.dgrpharma.com\/cms19\/wp-json\/wp\/v2\/posts\/932","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.dgrpharma.com\/cms19\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.dgrpharma.com\/cms19\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.dgrpharma.com\/cms19\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dgrpharma.com\/cms19\/wp-json\/wp\/v2\/comments?post=932"}],"version-history":[{"count":11,"href":"https:\/\/www.dgrpharma.com\/cms19\/wp-json\/wp\/v2\/posts\/932\/revisions"}],"predecessor-version":[{"id":1223,"href":"https:\/\/www.dgrpharma.com\/cms19\/wp-json\/wp\/v2\/posts\/932\/revisions\/1223"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.dgrpharma.com\/cms19\/wp-json\/wp\/v2\/media\/1224"}],"wp:attachment":[{"href":"https:\/\/www.dgrpharma.com\/cms19\/wp-json\/wp\/v2\/media?parent=932"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.dgrpharma.com\/cms19\/wp-json\/wp\/v2\/categories?post=932"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.dgrpharma.com\/cms19\/wp-json\/wp\/v2\/tags?post=932"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}